论文部分内容阅读
目的:规范心血管内科高危药品的管理,提高护理人员风险管理意识,提高用药的安全性。方法:成立高危药品管理小组,制订管理制度;筛选心血管内科高危药品目录;加强高危药品相关知识培训;设定高危药品专区专柜;规范高危药品的使用流程;依托医院信息支持体系的支持等,从而实现规范化管理。结果:实施高危药品规范化管理后,放置不规范、药物不良事件与实施前比较例数减少,两者差异有统计学意义(P<0.01);高危药品标识不清、高危药品知识掌握不全例数较前减少,两者比较有统计学差异(P<0.05);高危药品过期现象有所减少,但两者无统计学差异(P>0.05)。结论:心血管病区实施高危药品管理制度后,规范了高危药品的管理,提高了护理人员对高危药品的认识,有效地预防和减少了高危药品的药物不良事件发生。
OBJECTIVE: To standardize the management of high-risk medicines in cardiovascular medicine, raise the awareness of risk management among nursing staff and improve the safety of medication. Methods: The establishment of high-risk drug management team, the development of management system; Screening of cardiovascular medicine list of high-risk drugs; Strengthen the knowledge of high-risk drug training; Set high-risk drugs area counters; Regulate the use of high-risk drugs; Relying on hospital information support system support, In order to achieve standardized management. Results: After the implementation of standardized management of high-risk drugs, the number of adverse drug reactions was not standardized, and the number of adverse drug events decreased before and after implementation. The difference was statistically significant (P <0.01); the number of high-risk drugs was not clear and the number of high-risk drugs was incomplete (P <0.05). The outdated phenomenon of high-risk drugs decreased, but there was no significant difference between them (P> 0.05). Conclusion: After the implementation of high-risk drug management system in cardiovascular disease area, it regulates the management of high-risk drugs, enhances the nursing staff's understanding of high-risk drugs and effectively prevents and reduces the occurrence of adverse drug events in high-risk drugs.